BIOCON
|
BIOCON Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹811 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
| Equity - Authorised | ₹900 Cr | ₹625 Cr | ₹625 Cr | ₹625 Cr | ₹625 Cr |
| Equity - Issued | ₹811 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
| Equity Paid Up | ₹811 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr | ₹600 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
| Share Warrants & Outstandings | ₹514 Cr | ₹425 Cr | ₹320 Cr | ₹274 Cr | ₹204 Cr |
| Total Reserves | ₹32,707 Cr | ₹20,619 Cr | ₹18,863 Cr | ₹16,993 Cr | ₹7,628 Cr |
| Securities Premium | ₹15,560 Cr | ₹258 Cr | ₹229 Cr | ₹174 Cr | ₹119 Cr |
| Capital Reserves | ₹84 Cr | ₹84 Cr | ₹84 Cr | ₹80 Cr | ₹80 Cr |
| Profit & Loss Account Balance | ₹13,992 Cr | ₹18,959 Cr | ₹17,603 Cr | ₹16,086 Cr | ₹6,827 Cr |
| General Reserves | ₹188 Cr | ₹188 Cr | ₹188 Cr | ₹162 Cr | ₹162 Cr |
| Other Reserves | ₹2,883 Cr | ₹1,130 Cr | ₹760 Cr | ₹491 Cr | ₹440 Cr |
| Reserve excluding Revaluation Reserve | ₹32,706 Cr | ₹20,618 Cr | ₹18,862 Cr | ₹16,992 Cr | ₹7,627 Cr |
| Revaluation reserve | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr | ₹0.90 Cr |
| Shareholder's Funds | ₹34,032 Cr | ₹21,644 Cr | ₹19,784 Cr | ₹17,867 Cr | ₹8,433 Cr |
| Minority Interest | ₹2,590 Cr | ₹6,069 Cr | ₹5,491 Cr | ₹4,622 Cr | ₹1,038 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹10,476 Cr | ₹10,503 Cr | ₹11,268 Cr | ₹13,692 Cr | ₹2,574 Cr |
| Non Convertible Debentures | ₹7,360 Cr | ₹8,787 Cr | ₹1,832 Cr | ₹1,292 Cr | ₹200 Cr |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹3,629 Cr | ₹3,611 Cr | ₹10,083 Cr | ₹12,400 Cr | ₹2,384 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹-512 Cr | ₹-1,895 Cr | ₹-648 Cr | - | ₹-9.50 Cr |
| Unsecured Loans | ₹270 Cr | ₹1,903 Cr | ₹1,665 Cr | ₹1,598 Cr | ₹1,424 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹270 Cr | ₹295 Cr | ₹171 Cr | ₹195 Cr | ₹190 Cr |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | ₹1,608 Cr | ₹1,494 Cr | ₹1,403 Cr | ₹1,234 Cr |
| Deferred Tax Assets / Liabilities | ₹-314 Cr | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr |
| Deferred Tax Assets | ₹1,836 Cr | ₹1,142 Cr | ₹747 Cr | ₹710 Cr | ₹549 Cr |
| Deferred Tax Liability | ₹1,522 Cr | ₹1,242 Cr | ₹821 Cr | ₹791 Cr | ₹308 Cr |
| Other Long Term Liabilities | ₹1,642 Cr | ₹3,727 Cr | ₹1,876 Cr | ₹5,145 Cr | ₹2,954 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹330 Cr | ₹261 Cr | ₹238 Cr | ₹227 Cr | ₹92 Cr |
| Total Non-Current Liabilities | ₹12,404 Cr | ₹16,493 Cr | ₹15,120 Cr | ₹20,742 Cr | ₹6,803 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹6,772 Cr | ₹6,549 Cr | ₹6,272 Cr | ₹3,842 Cr | ₹1,609 Cr |
| Sundry Creditors | ₹6,772 Cr | ₹6,549 Cr | ₹6,272 Cr | ₹3,842 Cr | ₹1,609 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹3,059 Cr | ₹3,966 Cr | ₹6,481 Cr | ₹1,815 Cr | ₹1,031 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | ₹0.20 Cr |
| Advances received from customers | ₹670 Cr | ₹612 Cr | ₹517 Cr | ₹541 Cr | ₹445 Cr |
| Interest Accrued But Not Due | ₹266 Cr | ₹249 Cr | ₹18 Cr | ₹20 Cr | ₹14 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹2,124 Cr | ₹3,105 Cr | ₹5,947 Cr | ₹1,254 Cr | ₹573 Cr |
| Short Term Borrowings | ₹3,566 Cr | ₹3,455 Cr | ₹2,149 Cr | ₹2,480 Cr | ₹896 Cr |
| Secured ST Loans repayable on Demands | ₹1,473 Cr | ₹325 Cr | ₹42 Cr | ₹103 Cr | ₹38 Cr |
| Working Capital Loans- Sec | ₹1,473 Cr | ₹325 Cr | ₹42 Cr | ₹41 Cr | ₹38 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹620 Cr | ₹2,805 Cr | ₹2,066 Cr | ₹2,336 Cr | ₹820 Cr |
| Short Term Provisions | ₹672 Cr | ₹365 Cr | ₹456 Cr | ₹374 Cr | ₹292 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹416 Cr | ₹173 Cr | ₹277 Cr | ₹225 Cr | ₹162 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹256 Cr | ₹192 Cr | ₹180 Cr | ₹149 Cr | ₹131 Cr |
| Total Current Liabilities | ₹14,069 Cr | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr |
| Total Liabilities | ₹63,095 Cr | ₹58,540 Cr | ₹55,753 Cr | ₹51,742 Cr | ₹20,101 Cr |
| ASSETS | |||||
| Gross Block | ₹48,079 Cr | ₹40,804 Cr | ₹37,930 Cr | ₹35,321 Cr | ₹11,233 Cr |
| Less: Accumulated Depreciation | ₹11,593 Cr | ₹8,841 Cr | ₹7,287 Cr | ₹5,854 Cr | ₹4,664 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹36,486 Cr | ₹31,963 Cr | ₹30,644 Cr | ₹29,468 Cr | ₹6,569 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹4,613 Cr | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr |
| Non Current Investments | ₹1,089 Cr | ₹680 Cr | ₹684 Cr | ₹742 Cr | ₹370 Cr |
| Long Term Investment | ₹1,089 Cr | ₹680 Cr | ₹684 Cr | ₹742 Cr | ₹370 Cr |
| Quoted | ₹1,027 Cr | ₹624 Cr | ₹630 Cr | ₹12 Cr | ₹59 Cr |
| Unquoted | ₹78 Cr | ₹65 Cr | ₹59 Cr | ₹731 Cr | ₹312 Cr |
| Long Term Loans & Advances | ₹974 Cr | ₹871 Cr | ₹893 Cr | ₹683 Cr | ₹484 Cr |
| Other Non Current Assets | ₹380 Cr | ₹231 Cr | ₹361 Cr | ₹1,198 Cr | ₹185 Cr |
| Total Non-Current Assets | ₹45,915 Cr | ₹42,253 Cr | ₹40,574 Cr | ₹39,408 Cr | ₹11,718 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹690 Cr | ₹447 Cr | ₹316 Cr | ₹1,327 Cr | ₹1,218 Cr |
| Quoted | ₹690 Cr | ₹447 Cr | ₹316 Cr | ₹444 Cr | ₹252 Cr |
| Unquoted | - | - | - | ₹882 Cr | ₹966 Cr |
| Inventories | ₹6,086 Cr | ₹4,931 Cr | ₹4,944 Cr | ₹4,244 Cr | ₹2,298 Cr |
| Raw Materials | ₹1,162 Cr | ₹968 Cr | ₹837 Cr | ₹896 Cr | ₹602 Cr |
| Work-in Progress | ₹2,376 Cr | ₹1,723 Cr | ₹1,415 Cr | ₹1,371 Cr | ₹1,062 Cr |
| Finished Goods | ₹1,196 Cr | ₹915 Cr | ₹823 Cr | ₹401 Cr | ₹355 Cr |
| Packing Materials | ₹441 Cr | ₹430 Cr | ₹280 Cr | ₹377 Cr | ₹254 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹911 Cr | ₹895 Cr | ₹1,590 Cr | ₹1,198 Cr | ₹26 Cr |
| Sundry Debtors | ₹5,987 Cr | ₹5,488 Cr | ₹6,231 Cr | ₹3,573 Cr | ₹2,058 Cr |
| Debtors more than Six months | ₹214 Cr | ₹510 Cr | ₹900 Cr | ₹326 Cr | ₹95 Cr |
| Debtors Others | ₹5,858 Cr | ₹5,041 Cr | ₹5,396 Cr | ₹3,309 Cr | ₹1,999 Cr |
| Cash and Bank | ₹3,194 Cr | ₹4,120 Cr | ₹2,259 Cr | ₹2,400 Cr | ₹1,748 Cr |
| Cash in hand | - | - | - | - | - |
| Balances at Bank | ₹3,194 Cr | ₹4,120 Cr | ₹2,259 Cr | ₹2,400 Cr | ₹1,748 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹419 Cr | ₹383 Cr | ₹334 Cr | ₹334 Cr | ₹660 Cr |
| Interest accrued on Investments | - | - | - | ₹56 Cr | ₹62 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹242 Cr | ₹190 Cr | ₹157 Cr | ₹132 Cr | ₹87 Cr |
| Other current_assets | ₹177 Cr | ₹193 Cr | ₹177 Cr | ₹146 Cr | ₹511 Cr |
| Short Term Loans and Advances | ₹805 Cr | ₹917 Cr | ₹1,096 Cr | ₹456 Cr | ₹401 Cr |
| Advances recoverable in cash or in kind | ₹114 Cr | ₹177 Cr | ₹106 Cr | ₹150 Cr | ₹129 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | ₹160 Cr | ₹360 Cr | ₹538 Cr | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹531 Cr | ₹381 Cr | ₹452 Cr | ₹306 Cr | ₹272 Cr |
| Total Current Assets | ₹17,180 Cr | ₹16,286 Cr | ₹15,179 Cr | ₹12,334 Cr | ₹8,382 Cr |
| Net Current Assets (Including Current Investments) | ₹3,111 Cr | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹63,095 Cr | ₹58,540 Cr | ₹55,753 Cr | ₹51,742 Cr | ₹20,101 Cr |
| Contingent Liabilities | ₹928 Cr | ₹1,176 Cr | ₹1,136 Cr | ₹948 Cr | ₹844 Cr |
| Total Debt | ₹14,825 Cr | ₹17,756 Cr | ₹15,730 Cr | ₹17,771 Cr | ₹4,904 Cr |
| Book Value | 206.77 | 176.73 | 162.11 | 146.53 | 68.53 |
| Adjusted Book Value | 206.77 | 176.73 | 162.11 | 146.53 | 68.53 |
Compare Balance Sheet of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,795.5 Cr | -3.3% | -4.3% | 18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -3.3% |
-4.3% |
18.9% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses